{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:31:31Z","timestamp":1792161091670,"version":"4.4.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T00:00:00Z","timestamp":1684627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T00:00:00Z","timestamp":1684627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Systemic hypoxia occurs in COVID-19 infection; however, it is unknown if cerebral hypoxia occurs in convalescent individuals. We have evidence from other conditions associated with central nervous system inflammation that hypoxia may occur in the brain. If so, hypoxia could reduce the quality of life and brain function. This study was undertaken to assess if brain hypoxia occurs in individuals after recovery from acute COVID-19 infection and if this hypoxia is associated with neurocognitive impairment and reduced quality of life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using frequency-domain near-infrared spectroscopy (fdNIRS), we measured cerebral tissue oxygen saturation (S<jats:sub><jats:italic>t<\/jats:italic><\/jats:sub>O<jats:sub>2<\/jats:sub>) (a measure of hypoxia) in participants who had contracted COVID-19 at least 8\u00a0weeks prior to the study visit and healthy controls. We also conducted neuropsychological assessments and health-related quality of life assessments, fatigue, and depression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty-six percent of the post-COVID-19 participants self-reported having persistent symptoms (from a list of 18), with the most reported symptom being fatigue and brain fog. There was a gradation in the decrease of oxyhemoglobin between controls, and normoxic and hypoxic post-COVID-19 groups (31.7\u2009\u00b1\u20098.3\u00a0\u03bcM, 27.8\u2009\u00b1\u20097.0\u00a0\u03bcM and 21.1\u2009\u00b1\u20097.2\u00a0\u03bcM, respectively,<jats:italic>p<\/jats:italic>\u2009=\u20090.028,<jats:italic>p<\/jats:italic>\u2009=\u20090.005, and<jats:italic>p<\/jats:italic>\u2009=\u20090.081). We detected that 24% of convalescent individuals\u2019 post-COVID-19 infection had reduced S<jats:sub><jats:italic>t<\/jats:italic><\/jats:sub>O<jats:sub>2<\/jats:sub>in the brain and that this relates to reduced neurological function and quality of life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretation<\/jats:title><jats:p>We believe that the hypoxia reported here will have health consequences for these individuals, and this is reflected in the correlation of hypoxia with greater symptomology. With the fdNIRS technology, combined with neuropsychological assessment, we may be able to identify individuals at risk of hypoxia-related symptomology and target individuals that are likely to respond to treatments aimed at improving cerebral oxygenation.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s00415-023-11767-2","type":"journal-article","created":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T11:01:36Z","timestamp":1684666896000},"page":"3303-3314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Brain hypoxia, neurocognitive impairment, and quality of life in people post-COVID-19"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0312-2359","authenticated-orcid":false,"given":"Damilola D.","family":"Adingupu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ateyeh","family":"Soroush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayden","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Twomey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff F.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,21]]},"reference":[{"issue":"3","key":"11767_CR1","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14726","volume":"9","author":"L \u00d8stergaard","year":"2021","unstructured":"\u00d8stergaard L (2021) SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep 9(3):e14726","journal-title":"Physiol Rep"},{"issue":"3","key":"11767_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048391","volume":"11","author":"A Dennis","year":"2021","unstructured":"Dennis A et al (2021) Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 11(3):e048391","journal-title":"BMJ Open"},{"issue":"5","key":"11767_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M et al (2021) 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 8(5):416\u2013427","journal-title":"Lancet Psychiatry"},{"issue":"10270","key":"11767_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang C et al (2021) 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397(10270):220\u2013232","journal-title":"Lancet"},{"key":"11767_CR5","doi-asserted-by":"publisher","first-page":"993","DOI":"10.15585\/mmwr.mm6930e1","volume":"69","author":"MW Tenforde","year":"2020","unstructured":"Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files CD, Gibbs KW, Erickson HL, Steingrub JS, Smithline HA, Gong MN, Aboodi MS, Exline MC, Henning DJ, Wilson JG, Khan A, Qadir N, Brown SM, Peltan ID, Rice TW, Hager DN, Ginde AA, Stubblefield WB, Patel MM, Self WH, Feldstein LR, Hart KW, McClellan R, Dorough L, Dzuris N, Griggs EP, Kassem AM, Marcet PL, Ogokeh CE, Sciarratta CN, Siddula A, Smith ER, Wu MJ (2020) Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network \u2014 United States, March\u2013June 2020. MMWR Morb Mortal Wkly Rep 69:993\u2013998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"11767_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carf\u00ec","year":"2020","unstructured":"Carf\u00ec A et al (2020) Persistent Symptoms in Patients After Acute COVID-19. JAMA 324(6):603\u2013605","journal-title":"JAMA"},{"key":"11767_CR7","unstructured":"WHO (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. pp 1\u201327"},{"issue":"6578","key":"11767_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1126\/science.abm2052","volume":"375","author":"S Spudich","year":"2022","unstructured":"Spudich S, Nath A (2022) Nervous system consequences of COVID-19. Science 375(6578):267\u2013269","journal-title":"Science"},{"key":"11767_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroimage.2017.12.027","volume":"172","author":"F Corlier","year":"2018","unstructured":"Corlier F et al (2018) Systemic inflammation as a predictor of brain aging: contributions of physical activity, metabolic risk, and genetic risk. Neuroimage 172:118\u2013129","journal-title":"Neuroimage"},{"issue":"4","key":"11767_CR10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405","journal-title":"Lancet Neurol"},{"key":"11767_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2020.100163","volume":"9","author":"M Almeria","year":"2020","unstructured":"Almeria M et al (2020) Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health 9:100163","journal-title":"Brain Behav Immun Health"},{"issue":"9","key":"11767_CR12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","volume":"19","author":"MA Ellul","year":"2020","unstructured":"Ellul MA et al (2020) Neurological associations of COVID-19. Lancet Neurol 19(9):767\u2013783","journal-title":"Lancet Neurol"},{"key":"11767_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12950-020-00263-3","volume":"17","author":"M Jahani","year":"2020","unstructured":"Jahani M, Dokaneheifard S, Mansouri K (2020) Hypoxia: a key feature of COVID-19 launching activation of HIF-1 and cytokine storm. J Inflamm (Lond) 17:33","journal-title":"J Inflamm (Lond)"},{"issue":"13","key":"11767_CR14","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1177\/1352458518791683","volume":"25","author":"R Yang","year":"2019","unstructured":"Yang R, Dunn JF (2019) Multiple sclerosis disease progression: contributions from a hypoxia-inflammation cycle. Mult Scler 25(13):1715\u20131718","journal-title":"Mult Scler"},{"issue":"1","key":"11767_CR15","doi-asserted-by":"publisher","first-page":"16477","DOI":"10.1038\/srep16477","volume":"5","author":"R Yang","year":"2015","unstructured":"Yang R, Dunn JF (2015) Reduced cortical microvascular oxygenation in multiple sclerosis: a blinded, case-controlled study using a novel quantitative near-infrared spectroscopy method. Sci Rep 5(1):16477","journal-title":"Sci Rep"},{"issue":"4","key":"11767_CR16","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/hep.30920","volume":"71","author":"CC Duszynski","year":"2020","unstructured":"Duszynski CC et al (2020) Near-infrared spectroscopy reveals brain hypoxia and cerebrovascular dysregulation in primary biliary cholangitis. Hepatology 71(4):1408\u20131420","journal-title":"Hepatology"},{"key":"11767_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-4939-3023-4_17","volume":"876","author":"D Highton","year":"2016","unstructured":"Highton D et al (2016) Near infrared light scattering changes following acute brain injury. Adv Exp Med Biol 876:139\u2013144","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"11767_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/BF02523048","volume":"33","author":"RA De Blasi","year":"1995","unstructured":"De Blasi RA et al (1995) Cerebral and muscle oxygen saturation measurement by frequency-domain near-infra-red spectrometer. Med Biol Eng Comput 33(2):228\u2013230","journal-title":"Med Biol Eng Comput"},{"issue":"2","key":"11767_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jneumeth.2006.04.013","volume":"157","author":"R Gatto","year":"2006","unstructured":"Gatto R et al (2006) Frequency domain near-infrared spectroscopy technique in the assessment of brain oxygenation: a validation study in live subjects and cadavers. J Neurosci Methods 157(2):274\u2013277","journal-title":"J Neurosci Methods"},{"issue":"6","key":"11767_CR20","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1088\/0031-9155\/44\/6\/308","volume":"44","author":"S Fantini","year":"1999","unstructured":"Fantini S et al (1999) Non-invasive optical monitoring of the newborn piglet brain using continuous-wave and frequency-domain spectroscopy. Phys Med Biol 44(6):1543\u20131563","journal-title":"Phys Med Biol"},{"issue":"1","key":"11767_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1152\/japplphysiol.01138.2018","volume":"127","author":"SM Hammer","year":"2019","unstructured":"Hammer SM et al (2019) Effect of assuming constant tissue scattering on measured tissue oxygenation values during tissue ischemia and vascular reperfusion. J Appl Physiol (1985) 127(1):22\u201330","journal-title":"J Appl Physiol (1985)"},{"key":"11767_CR22","volume-title":"Handbook of normative data for neuropsychological assessment. Vol","author":"MN Mitrushina","year":"2005","unstructured":"Mitrushina MN (2005) Handbook of normative data for neuropsychological assessment. Vol, 2nd edn. Oxford University Press, Oxford","edition":"2"},{"key":"11767_CR23","volume-title":"Symbol digit modalities test (SDMT). Manual (Revised)","author":"A Smith","year":"1982","unstructured":"Smith A (1982) Symbol digit modalities test (SDMT). Manual (Revised). Western Psychological Services, Los Angeles"},{"issue":"5","key":"11767_CR24","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1177\/1352458506070624","volume":"12","author":"E Rosti","year":"2006","unstructured":"Rosti E et al (2006) The PASAT performance among patients with multiple sclerosis: analyses of responding patterns using different scoring methods. Mult Scler 12(5):586\u2013593","journal-title":"Mult Scler"},{"issue":"24","key":"11767_CR25","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","volume":"25","author":"JE Ware Jr","year":"2000","unstructured":"Ware JE Jr (2000) SF-36 health survey update. Spine (Phila Pa 1976) 25(24):3130\u20133139","journal-title":"Spine (Phila Pa 1976)"},{"issue":"2","key":"11767_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB et al (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13(2):63\u201374","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"11767_CR27","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/ene.12932","volume":"23","author":"R Sacco","year":"2016","unstructured":"Sacco R et al (2016) Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. Eur J Neurol 23(4):744\u2013750","journal-title":"Eur J Neurol"},{"key":"11767_CR28","doi-asserted-by":"crossref","unstructured":"Twomey R, DeMars J, Franklin K, Culos-Reed SN, Weatherald J, Wrightson JG\u00a0(2022) Chronic fatigue and postexertional Malaise in people living with long COVID: an observational study. Phys Ther 102(4)","DOI":"10.1093\/ptj\/pzac005"},{"key":"11767_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-1-79","volume":"1","author":"K Webster","year":"2003","unstructured":"Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1:79","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"11767_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00520-004-0734-y","volume":"13","author":"S Van Belle","year":"2005","unstructured":"Van Belle S et al (2005) Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Support Care Cancer 13(4):246\u2013254","journal-title":"Support Care Cancer"},{"issue":"11A","key":"11767_CR31","first-page":"369","volume":"12","author":"D Cella","year":"1998","unstructured":"Cella D et al (1998) Progress toward guidelines for the management of fatigue. Oncology (Williston Park) 12(11A):369\u2013377","journal-title":"Oncology (Williston Park)"},{"issue":"1","key":"11767_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/annonc\/mdn537","volume":"20","author":"O Minton","year":"2009","unstructured":"Minton O, Stone P (2009) A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol 20(1):17\u201325","journal-title":"Ann Oncol"},{"issue":"1","key":"11767_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jpsychores.2012.10.011","volume":"74","author":"Z Butt","year":"2013","unstructured":"Butt Z et al (2013) Measurement of fatigue in cancer, stroke, and HIV using the Functional Assessment of Chronic Illness Therapy-fatigue (FACIT-F) scale. J Psychosom Res 74(1):64\u201368","journal-title":"J Psychosom Res"},{"issue":"5","key":"11767_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1177\/0961203313476360","volume":"22","author":"M Kosinski","year":"2013","unstructured":"Kosinski M et al (2013) Qualitative validation of the FACIT-fatigue scale in systemic lupus erythematosus. Lupus 22(5):422\u2013430","journal-title":"Lupus"},{"issue":"5","key":"11767_CR35","first-page":"811","volume":"32","author":"D Cella","year":"2005","unstructured":"Cella D et al (2005) Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32(5):811\u2013819","journal-title":"J Rheumatol"},{"issue":"7","key":"11767_CR36","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/ard.2006.065763","volume":"66","author":"V Chandran","year":"2007","unstructured":"Chandran V et al (2007) Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Ann Rheum Dis 66(7):936\u2013939","journal-title":"Ann Rheum Dis"},{"key":"11767_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1477-7525-10-100","volume":"10","author":"K Al-shair","year":"2012","unstructured":"Al-shair K et al (2012) Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes 10:100","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"11767_CR38","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jpainsymman.2006.05.021","volume":"32","author":"P Hagell","year":"2006","unstructured":"Hagell P et al (2006) Measuring fatigue in Parkinson\u2019s disease: a psychometric study of two brief generic fatigue questionnaires. J Pain Symptom Manage 32(5):420\u2013432","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"11767_CR39","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/BF03654803","volume":"24","author":"KF Tennant","year":"2012","unstructured":"Tennant KF et al (2012) A preliminary study of symptomatic fatigue in rural older adults. Aging Clin Exp Res 24(4):324\u2013330","journal-title":"Aging Clin Exp Res"},{"key":"11767_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12955-015-0257-x","volume":"13","author":"S Acaster","year":"2015","unstructured":"Acaster S et al (2015) Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia. Health Qual Life Outcomes 13:60","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"11767_CR41","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/s41467-022-29440-z","volume":"13","author":"I Rutkai","year":"2022","unstructured":"Rutkai I et al (2022) Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun 13(1):1745","journal-title":"Nat Commun"},{"key":"11767_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100122","volume":"6","author":"M Augustin","year":"2021","unstructured":"Augustin M et al (2021) Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 6:100122","journal-title":"Lancet Reg Health Eur"},{"issue":"12","key":"11767_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-006434","volume":"6","author":"K Romero Starke","year":"2021","unstructured":"Romero Starke K et al (2021) The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis. BMJ Glob Health 6(12):e006434","journal-title":"BMJ Glob Health"},{"key":"11767_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.698169","author":"AD Proal","year":"2021","unstructured":"Proal AD, VanElzakker MB (2021) Long COVID or Post-acute Sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2021.698169","journal-title":"Front Microbiol"},{"issue":"1","key":"11767_CR45","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41392-021-00726-w","volume":"6","author":"M Tian","year":"2021","unstructured":"Tian M et al (2021) HIF-1\u03b1 promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal Transduct Target Ther 6(1):308","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"11767_CR46","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMc2019373","volume":"383","author":"IH Solomon","year":"2020","unstructured":"Solomon IH et al (2020) Neuropathological features of Covid-19. N Engl J Med 383(10):989\u2013992","journal-title":"N Engl J Med"},{"issue":"5","key":"11767_CR47","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJMc2033369","volume":"384","author":"M-H Lee","year":"2020","unstructured":"Lee M-H et al (2020) Microvascular Injury in the Brains of Patients with Covid-19. N Engl J Med 384(5):481\u2013483","journal-title":"N Engl J Med"},{"issue":"7907","key":"11767_CR48","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","volume":"604","author":"G Douaud","year":"2022","unstructured":"Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, Lange F, Andersson JLR, Griffanti L, Duff E, Jbabdi S, Taschler B, Keating P, Winkler AM, Collins R, Matthews PM, Allen N, Miller KL, Nichols TE, Smith SM (2022) SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604(7907):697\u2013707","journal-title":"Nature"},{"issue":"11","key":"11767_CR49","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/s41593-021-00926-1","volume":"24","author":"J Wenzel","year":"2021","unstructured":"Wenzel J et al (2021) The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci 24(11):1522\u20131533","journal-title":"Nat Neurosci"},{"key":"11767_CR50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147329","author":"Y Qin","year":"2021","unstructured":"Qin Y et al (2021) Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI147329","journal-title":"J Clin Invest"},{"issue":"4","key":"11767_CR51","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.12378","volume":"3","author":"R Yang","year":"2015","unstructured":"Yang R et al (2015) Studying cerebral hemodynamics and metabolism using simultaneous near-infrared spectroscopy and transcranial Doppler ultrasound: a hyperventilation and caffeine study. Physiol Rep 3(4):e12378","journal-title":"Physiol Rep"},{"issue":"7","key":"11767_CR52","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1093\/brain\/awac151","volume":"145","author":"MH Lee","year":"2022","unstructured":"Lee MH et al (2022) Neurovascular injury with complement activation and inflammation in COVID-19. Brain 145(7):2555\u20132568","journal-title":"Brain"},{"issue":"11","key":"11767_CR53","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.bbabio.2014.08.005","volume":"1837","author":"MG Mason","year":"2014","unstructured":"Mason MG, Nicholls P, Cooper CE (2014) Re-evaluation of the near infrared spectra of mitochondrial cytochrome c oxidase: implications for non invasive in vivo monitoring of tissues. Biochim Biophys Acta 1837(11):1882\u20131891","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"11767_CR54","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1097\/MAT.0000000000000453","volume":"63","author":"F Tian","year":"2017","unstructured":"Tian F et al (2017) Regional cerebral abnormalities measured by frequency-domain near-infrared spectroscopy in pediatric patients during extracorporeal membrane oxygenation. Asaio j 63(5):e52\u2013e59","journal-title":"Asaio j"},{"issue":"2","key":"11767_CR55","first-page":"73","volume":"2","author":"S Goodall","year":"2014","unstructured":"Goodall S, Twomey R, Amann M (2014) Acute and chronic hypoxia: implications for cerebral function and exercise tolerance. Fatigue 2(2):73\u201392","journal-title":"Fatigue"},{"issue":"1","key":"11767_CR56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11065-021-09500-9","volume":"32","author":"AB Marcinkowska","year":"2022","unstructured":"Marcinkowska AB et al (2022) Impact of hyperbaric oxygen therapy on cognitive functions: a systematic review. Neuropsychol Rev 32(1):99\u2013126","journal-title":"Neuropsychol Rev"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11767-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11767-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11767-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T13:47:51Z","timestamp":1702475271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11767-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,21]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["11767"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11767-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,21]]},"assertion":[{"value":"25 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study complied with the Declaration of Helsinki. Ethics approval was obtained from the Conjoint Health and Research Board at the University of Calgary.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard statement"}}]}}